Literature DB >> 6578657

Etiology and pathogenesis of monophasic and relapsing inflammatory demyelination - human and experimental.

H M Wisniewski, H Lassmann.   

Abstract

The close similarity of the CNS lesions in cr-EAE and MS renders this model especially valuable for the study of pathogenetic factors, leading to the formation of inflammatory demyelinated plaques. Recent evidence indicates, that various immune reactions, directed against different CNS antigens cooperate in the formation of the plaques. Furthermore it is discussed, that a combination of virus infection and autoimmunity may result in similarity structured lesions. It is thus propose that multiple different etiologic factors (autoimmune as well as exogenous events) may lead to the clinical pathohistological syndrome of multiple sclerosis.

Entities:  

Mesh:

Year:  1983        PMID: 6578657     DOI: 10.1007/978-3-642-69094-5_3

Source DB:  PubMed          Journal:  Acta Neuropathol Suppl        ISSN: 0065-1435


  4 in total

1.  Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood-brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis.

Authors:  A S Lossinsky; V Badmajew; J A Robson; R C Moretz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Induction of synchronized relapses in SJL/J mice with chronic relapsing experimental allergic encephalomyelitis.

Authors:  P B Kozlowski; G B Schuller-Lewis; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Extravasation of polymorphonuclear leukocytes from the cerebral microvasculature. Inflammatory response induced by alpha-bungarotoxin.

Authors:  P M Faustmann; R Dermietzel
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

4.  Characteristics of in vitro cytotoxic effects of myelin basic protein-reactive T cell lines on syngeneic oligodendrocytes.

Authors:  K Kawai; B Zweiman
Journal:  J Neuroimmunol       Date:  1990-01       Impact factor: 3.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.